DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T-cell tolerance and inhibit diabetes

Diabetes

Volumn 64, Issue 10, 2015, Pages 3521-3531

  Price, Jeffrey D ^a   Hotta Iwamura, Chie ^a   Zhao, Yongge ^a   Beauchamp, Nicole M ^a   Tarbell, Kristin V ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD69 ANTIGEN; DENDRITIC CELL INHIBITORY RECEPTOR 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER AND BTB DOMAIN CONTAINING 32 PROTEIN; ANTIBODY; CD40 ANTIGEN; CELL SURFACE RECEPTOR; DCIR2 PROTEIN, MOUSE; DEC-205 RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; LECTIN; LEUKOCYTE ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; REPRESSOR PROTEIN; ROG PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CELL MIGRATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DIABETES MELLITUS; DIABETOGENESIS; GENE EXPRESSION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; LEUKOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; PHYSIOLOGY;

ANIMALS; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD40; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DIABETES MELLITUS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MINOR HISTOCOMPATIBILITY ANTIGENS; RECEPTORS, CELL SURFACE; REPRESSOR PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84947504060     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1880     Document Type: Article

References (50)

1. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010; 464:1293-1300
2. Clemente-Casares X., Tsai S, Huang C., Santamaria P. Antigen-specific therapeutic approaches in type 1 diabetes. Cold Spring Harb Perspect Med 2012; 2:a007773
3. Ben-Nun A., Kaushansky N, Kawakami N., et al. From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding patho-genesis and drug development. J Autoimmun 2014; 54:33-50
4. Jayasimhan A, Mansour KP, Slattery RM Advances in our understanding of the pathophysiology of type 1 diabetes: lessons from the NOD mouse. Clin Sci (Lond) 2014; 126:1-18
5. Price JD, Tarbell KV The role of dendritic cell subsets and innate immunity in the pathogenesis of type 1 diabetes and other autoimmune diseases [article online], 2015. Front Immunol. Available from http://dx.doi.org/10.3389/fimmu.2015.00288. Accessed 15 June 2015
6. Welzen-Coppens J.M., van Helden-Meeuwsen CG, Leenen PJ, Drexhage HA, Versnel MA. Reduced numbers of dendritic cells with a tolerogenic phenotype in the prediabetic pancreas of NOD mice. J Leukoc Biol 2012; 92:1207-1213
7. Calderon B, Carrero JA, Miller M.J., Unanue ER. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci U S A 2011; 108:1561-1566
8. Morel PA. Dendritic cell subsets in type 1 diabetes: friend or foe? Front Immunol 2013; 4:415
9. Turley SJ. Dendritic cells: inciting and inhibiting autoimmunity. Curr Opin Immunol 2002; 14:765-770
10. Guilliams M, Ginhoux F, Jakubzick C., et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 2014; 14:571-578
11. Bachem A, Güttler S, Hartung E., et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 2010; 207:1273-1281
12. Hildner K, Edelson BT, Purtha W.E., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008; 322:1097-1100
13. Iyoda T, Shimoyama S, Liu K., et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195: 1289-1302
14. Liu K, Iyoda T, Saternus M., Kimura Y, Inaba K, Steinman RM Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002; 196:1091-1097
15. Ferris ST, Carrero JA, Mohan J.F., Calderon B., Murphy KM, Unanue ER. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes. Immunity 2014; 41:657-669
16. Jeker LT, Bour-Jordan H, Bluestone JA. Breakdown in peripheral tolerance in type 1 diabetes in mice and humans. Cold Spring Harb Perspect Med 2012; 2: a007807
17. Jansen A, van Hagen M, Drexhage HA. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 1995; 345:491-492
18. Price JD, Beauchamp NM, Rahir G, et al CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L. J Leukoc Biol 2014; 95:325-336
19. Steptoe RJ, Ritchie JM, Harrison LC Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice. J Immunol 2002; 168:5032-5041
20. Judkowski V, Pinilla C, Schroder K., Tucker L, Sarvetnick N, Wilson DB Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J Immunol 2001; 166:908-917
21. Haskins K, Portas M, Bergman B., Lafferty K, Bradley B. Pancreatic isletspecific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci U S A 1989; 86:8000-8004
22. Stadinski BD, Delong T, Reisdorph N., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010; 11:225-231
23. Feuerer M, Shen Y, Littman D.R., Benoist C., Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009; 31:654-664
24. Tang Q, Adams JY, Penaranda C, et al Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008; 28: 687-697
25. Spencer J, Peakman M. Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell. Clin Exp Immunol 2009; 155:125-127
26. Fu W, Wojtkiewicz G, Weissleder R., Benoist C, Mathis D. Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat Immunol 2012; 13:361-368
27. Lebastchi J, Herold KC Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes. Cold Spring Harb Perspect Med 2012; 2:a007708
28. Sosenko JM, Palmer JP, Greenbaum C.J., et al.; Diabetes Prevention TrialType 1 Study Group. Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care 2007; 30:38-42
29. Hawiger D, Inaba K, Dorsett Y., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769-779
30. Bonifaz L, Bonnyay D, Mahnke K., Rivera M, Nussenzweig MC, Steinman RM Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002; 196:1627-1638
31. Dudziak D, Kamphorst AO, Heidkamp G.F., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007; 315:107-111
32. Kamphorst AO, Guermonprez P, Dudziak D., Nussenzweig MC. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J Immunol 2010; 185:3426-3435
33. Bruder D, Westendorf AM, Hansen W, et al On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 2005; 54:3395-3401
34. Idoyaga J, Fiorese C, Zbytnuik L., et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest 2013; 123:844-854
35. Neubert K, Lehmann CH, Heger L, et al Antigen delivery to CD11c+CD8-dendritic cells induces protective immune responses against experimental melanoma in mice in vivo. J Immunol 2014; 192:5830-5838
36. Zang YS, Fang Z, Liu Y.A., Li B., Xiu QY. Repressor of GATA-3 can negatively regulate the expression of T cell cytokines through modulation on inducible costimulator. Chin Med J (Engl) 2012; 125:2188-2194
37. Clynes RA, Towers TL, Presta L.G., Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 2000; 6:443-446
38. + T cells. Immunity 2013; 39:560-572
39. Skokos D, Shakhar G, Varma R., et al. Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes. Nat Immunol 2007; 8:835-844
40. Haskins K, Cooke A. CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes. Curr Opin Immunol 2011; 23:739-745
41. Yamazaki S, Dudziak D, Heidkamp G.F., et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol 2008; 181:6923-6933
42. Hirahara K, Yamashita M, Iwamura C., et al. Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness. J Allergy Clin Immunol 2008; 122:512.e11-520.e11
43. Yoon HS, Scharer CD, Majumder P, et al ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells. J Immunol 2012; 189:2393-2403
44. Beaulieu AM, Zawislak CL, Nakayama T, Sun JC The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat Immunol 2014; 15:546-553
45. Miaw SC, Kang BY, White I.A., Ho IC. A repressor of GATA-mediated negative feedback mechanism of T cell activation. J Immunol 2004; 172:170-177
46. Tarbell KV, Yamazaki S, Olson K., Toy P, Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004; 199:1467-1477
47. Tarbell KV, Petit L, Zuo X., et al. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 2007; 204:191-201
48. Enzler T, Gillessen S, Dougan M., et al. Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells. Blood 2007; 110:954-961
49. Ito A, Aoyanagi N, Maki T. Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice. J Autoimmun 1997; 10: 331-338
50. + T cells. Immunity 2015; 42:265-278